Lakefront Biotherapeutics NV (GLPGN) Q3 2019 Earnings Report
MX:GLPGN Q3 2019 EPS Results
- Actual EPS
- MXN 121.13
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 5.82
MX:GLPGN Q3 2019 Revenue Results
- Actual Revenue
- MXN 13.17B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +568.19%
Earnings Announcement Details
- Quarter
- Q3 2019
- Date
- 10/24/2019
- Time
- TBA
- Conference Call
- Thursday, October 24, 2019
MX:GLPGN Upcoming Earnings
Lakefront Biotherapeutics NV's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q3 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:GLPGN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -14.91- | -63.77 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -14.540.62 | -32.82 | 101.90% (+33.44) | |
| May 06, 2026 | 2026 (Q1) | -16.934.36 | -48.82 | 108.94% (+53.18) | |
| Feb 23, 2026 | 2025 (Q4) | -2.29246.57 | 6 | 4007.27% (+240.57) | |
| Nov 05, 2025 | 2025 (Q3) | -8.52-63.77 | -15.37 | -314.86% (-48.40) | |
| Jul 23, 2025 | 2025 (Q2) | -4.13-32.82 | 1.45 | -2357.14% (-34.28) | |
| Apr 23, 2025 | 2025 (Q1) | -2.83-48.82 | 7.48 | -752.78% (-56.29) | |
| Feb 12, 2025 | 2024 (Q4) | -10.616.00 | 49.65 | -87.91% (-43.64) | |
| Oct 30, 2024 | 2024 (Q3) | -3.22-15.37 | 8.1 | -289.74% (-23.47) | |
| Aug 01, 2024 | 2024 (Q2) | -1.411.45 | 1.66 | -12.50% (-0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
